Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016492
Filing Date
2022-08-10
Accepted
2022-08-10 16:27:21
Documents
66
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rani-20220630.htm   iXBRL 10-Q 2207602
2 EX-4.2 rani-ex4_2.htm EX-4.2 59403
3 EX-10.1 rani-ex10_1.htm EX-10.1 572891
4 EX-10.2 rani-ex10_2.htm EX-10.2 524173
5 EX-10.3 rani-ex10_3.htm EX-10.3 183401
6 EX-31.1 rani-ex31_1.htm EX-31.1 13953
7 EX-31.2 rani-ex31_2.htm EX-31.2 13978
8 EX-32.1 rani-ex32_1.htm EX-32.1 8729
9 GRAPHIC img208645564_0.jpg GRAPHIC 1466
  Complete submission text file 0000950170-22-016492.txt   9226690

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rani-20220630.xsd EX-101.SCH 58327
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rani-20220630_def.xml EX-101.DEF 305515
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rani-20220630_lab.xml EX-101.LAB 494432
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rani-20220630_cal.xml EX-101.CAL 35958
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rani-20220630_pre.xml EX-101.PRE 398241
60 EXTRACTED XBRL INSTANCE DOCUMENT rani-20220630_htm.xml XML 1153124
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40672 | Film No.: 221152171
SIC: 2834 Pharmaceutical Preparations